… The risk of thromboembolism and need for oral anticoagulation after successful atrial
fibrillation ablation. J Am Coll … The risk of thromboembolism and need for oral anticoagulation …

… Our results indicate a low thromboembolic risk after successful AF ablation. Previous
history of IS/TIA/SE and diabetes mellitus were independently associated with an increased …

… In summary, DOACs have been found to be safer and more effective than warfarin for the …
on VTE treatment have shown that, for both young and elderly patients, DOACs have similar …

… with patients continuing long-term OAC after successful ablation, the thromboembolic risk
was low in patients discontinuing long-term OAC (0.54 vs 0.86 per 100 patient-years), as was …

… Since 2009, four direct oral anticoagulants (DOACs) have been compared with VKA therapy
… Following ablation, regardless of the success of the procedure, there is consensus among …

… OAC therapy after CA according to the thromboembolic risk. … of continuing OACs after CA
and the occurrence of thromboembolic and … continuing OACs according to thromboembolic risk. …

… An effective and safe oral anticoagulation (OAC) strategy for patients with new postoperative
AF (POAF) after … and 1) thromboembolic events and 2) major bleeding in patients with POAF …

… It is plausible, however, that an effective rhythm control strategy might reduce the need for
… The risk of stroke and systemic embolism with OAC discontinuation varied according to …

… Direct oral anticoagulants are at least as effective as vitamin K antagonists in … thromboembolic
events in patients with non-valvular atrial fibrillation and safer in reducing the risk of …

… Direct oral anticoagulants (DOACs) have emerged as effective alternatives to vitamin K
antagonists (VKA) for preventing thromboembolic events in patients with AF. The Asian Pacific …